Newsroom
-
July 22 , 2020
Malaria breakthrough set to change vaccine design
- Researchers from the Australian National University (ANU) have discovered a vital clue as to why malaria vaccines keep failing, which could potentially change how vaccines for the deadly disease and others are made.
Read more -
July 21 , 2020
Levothyroxine doesn't improve cardiac function for heart attack patients
- Research reveals that treatment of heart attack patients for a common condition, underactive thyroid, with levothyroxine does not improve heart muscle function, so is unlikely to be of benefit.
Read more -
July 21 , 2020
Non-invasive blood test can detect cancer four years before conventional diagnosis methods
- An international team of researchers has developed a non-invasive blood test that can detect whether an individual has one of five common types of cancers, four years before the condition can be diagnosed with current methods. The test detects stomach, esophageal, colorectal, lung and liver cancer.
Read more -
July 20 , 2020
Experimental drug reduces replication of zika virus and prevents microcephaly in mice
- An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor)—a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation—enables the immune system to combat replication of zika virus in the organism far more effectively. In experiments performed at the University of São Paulo's Biom
Read more -
July 20 , 2020
Scientists identify a new drug target for dry age-related macular degeneration
- Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. The study, published in the Proceedings of the National Academy of Sciences (PNAS), also holds implicat
Read more